Qadri Ishtiaq, Hu Ling-Jia, Iwahashi Mieko, Al-Zuabi Subhi, Quattrochi Linda C, Simon Francis R
NUST Center of Virology and Immunology, National University of Science and Technology, Tamizudin Road, Rawalpindi, Pakistan.
Toxicol Appl Pharmacol. 2009 Feb 1;234(3):281-92. doi: 10.1016/j.taap.2008.10.005. Epub 2008 Oct 29.
Multidrug resistance-associated protein 2 (MRP2) (ABCC2) is an ATP-binding cassette membrane protein located primarily on apical surface of hepatocytes that mediates transport of conjugated xenobiotics and endogenous compounds into bile. MRP2 is highly expressed in hepatocytes, and at lower levels in small intestines, stomach and kidney. Previous reports have characterized mammalian MRP2 promoters, but none have established the molecular mechanism(s) involved in liver enriched expression. This study aims to investigate the mechanism of hepatic MRP2 regulation. A 2130 bp of MRP2 promoter was cloned from PAC-1 clone P108G1-7, to identify putative liver specific/hormone responsive functional DNA binding sites. Using deletion analysis, site specific mutagenesis and co-transfection studies, liver specific expression was determined. MRP2 promoter-LUC constructs were highly expressed in liver cell lines compared to non-liver cells. The region extending from -3 to+458 bp of MRP2 promoter starting from AUG contained the potential binding sites for CAATT box enhancer binding protein (C/EBP), hepatocytes nuclear factor 1, 3 and 4 (HNF1, HNF3, and HNF4. Only HNF1 and HNF4 co-transfection with MRP2 luciferase increased expression. Site specific mutational analysis of HNF1 binding site indicated an important role for HNF1alpha. HNF4alpha induction of MRP2 was independent of HNF1 binding site. C/EBP, HNF3, and HNF6 inhibited HNF1alpha while HNF4alpha induced MRP2 luciferase expression and glucocorticoids stimulated MRP2 expression. This study emphasizes the complex regulation of MRP2 with HNF1alpha and HNF4alpha playing a central role. The coordinated regulation of xenobiotic transporters and oxidative conjugation may determine the adaptive responses to cellular detoxification processes.
多药耐药相关蛋白2(MRP2)(ABCC2)是一种ATP结合盒膜蛋白,主要位于肝细胞的顶膜,介导结合型外源性物质和内源性化合物向胆汁中的转运。MRP2在肝细胞中高度表达,在小肠、胃和肾脏中的表达水平较低。先前的报道已对哺乳动物MRP2启动子进行了表征,但尚未确定参与肝脏富集表达的分子机制。本研究旨在探讨肝脏MRP2调控的机制。从PAC-1克隆P108G1-7中克隆出2130 bp的MRP2启动子,以鉴定假定的肝脏特异性/激素反应性功能DNA结合位点。通过缺失分析、位点特异性诱变和共转染研究,确定肝脏特异性表达。与非肝细胞系相比,MRP2启动子-LUC构建体在肝细胞系中高度表达。从AUG开始的MRP2启动子-3至+458 bp区域包含CAATT盒增强子结合蛋白(C/EBP)、肝细胞核因子1、3和4(HNF1、HNF3和HNF4)的潜在结合位点。只有HNF1和HNF4与MRP2荧光素酶共转染可增加表达。HNF1结合位点的位点特异性突变分析表明HNF1α起重要作用。HNF4α对MRP2的诱导独立于HNF1结合位点。C/EBP、HNF3和HNF6抑制HNF1α,而HNF4α诱导MRP2荧光素酶表达,糖皮质激素刺激MRP2表达。本研究强调了MRP2的复杂调控,其中HNF1α和HNF4α起核心作用。外源性物质转运体和氧化结合的协同调控可能决定细胞解毒过程的适应性反应。